RECRUITING

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To develop and test liver cancer prevention educational material.

Official Title

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Quick Facts

Study Start:2025-05-01
Study Completion:2027-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07010315

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * At least 18 years old
  2. * Participants at the HOPE Clinic
  3. * Able to speak and read either English or Spanish
  4. * For usability testing: Able to use and navigate websites on own smart phone or study computer
  1. * Has been diagnosed with liver cancer
  2. * Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)

Contacts and Locations

Study Contact

Jessica Hwang, MD, MPH
CONTACT
(346) 720-7352
jphwang@mdanderson.org

Principal Investigator

Jessica Hwang, MD, MPH
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Jessica Hwang, MD, MPH, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-01
Study Completion Date2027-04-30

Study Record Updates

Study Start Date2025-05-01
Study Completion Date2027-04-30

Terms related to this study

Keywords Provided by Researchers

  • Liver cancer
  • Liver disease
  • Fibrosis
  • Cirrhosis

Additional Relevant MeSH Terms

  • Liver Cancer